Rani Therapeutics Holdings, Inc.
RANI
$1.11
$0.010.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.05% | 26.25% | 26.85% | 10.62% | 19.21% |
| Total Depreciation and Amortization | 17.18% | 18.81% | 34.92% | 31.91% | 30.46% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 141.12% | 71.49% | 41.86% | 24.44% | 40.05% |
| Change in Net Operating Assets | 62.14% | 24.07% | -93.56% | 155.04% | -85.37% |
| Cash from Operations | 30.64% | 41.20% | 26.60% | 22.64% | 14.70% |
| Capital Expenditure | 81.44% | 73.90% | 71.94% | 92.74% | 68.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.01% | -95.11% | 488.88% | 135.92% | 18,312.33% |
| Cash from Investing | -81.01% | -95.98% | 727.00% | 149.67% | 3,004.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9,668.75% | 11,397.44% | 85.39% | -8.33% | -21.95% |
| Repurchase of Common Stock | -- | 51.72% | -166.67% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,753.13% | 15,622.45% | 76.25% | 1,412.50% | -99.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.74% | 90.81% | 79.33% | 112.63% | 520.75% |